211 related articles for article (PubMed ID: 24983965)
1. Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.
Catenacci DV; Liao WL; Thyparambil S; Henderson L; Xu P; Zhao L; Rambo B; Hart J; Xiao SY; Bengali K; Uzzell J; Darfler M; Krizman DB; Cecchi F; Bottaro DP; Karrison T; Veenstra TD; Hembrough T; Burrows J
PLoS One; 2014; 9(7):e100586. PubMed ID: 24983965
[TBL] [Abstract][Full Text] [Related]
2. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Catenacci DV; Ang A; Liao WL; Shen J; O'Day E; Loberg RD; Cecchi F; Hembrough T; Ruzzo A; Graziano F
Cancer; 2017 May; 123(6):1061-1070. PubMed ID: 27926778
[TBL] [Abstract][Full Text] [Related]
3. Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
Catenacci DVT; Liao WL; Zhao L; Whitcomb E; Henderson L; O'Day E; Xu P; Thyparambil S; Krizman D; Bengali K; Uzzell J; Darfler M; Cecchi F; Blackler A; Bang YJ; Hart J; Xiao SY; Lee SM; Burrows J; Hembrough T
Gastric Cancer; 2016 Oct; 19(4):1066-1079. PubMed ID: 26581548
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers.
Wang M; Liang L; Lei X; Multani A; Meric-Bernstam F; Tripathy D; Wu Y; Chen H; Zhang H
Ann Diagn Pathol; 2018 Aug; 35():69-76. PubMed ID: 29843069
[TBL] [Abstract][Full Text] [Related]
5. Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.
Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Taylor P; Tong J; Lara-Guerra H; Waddell TK; Moran MF; Tsao MS; Krizman DB; Burrows J
Clin Proteomics; 2012 May; 9(1):5. PubMed ID: 22554165
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
Bubendorf L; Dafni U; Schöbel M; Finn SP; Tischler V; Sejda A; Marchetti A; Thunnissen E; Verbeken EK; Warth A; Sansano I; Cheney R; Speel EJM; Nonaka D; Monkhorst K; Hager H; Martorell M; Savic S; Kerr KM; Tan Q; Tsourti Z; Geiger TR; Kammler R; Schulze K; Das-Gupta A; Shames D; Peters S; Stahel RA;
Lung Cancer; 2017 Sep; 111():143-149. PubMed ID: 28838386
[TBL] [Abstract][Full Text] [Related]
7. Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?
Mikhail S; Ciombor K; Noonan A; Wu C; Goldberg R; Zhao W; Wei L; Mathey K; Yereb M; Timmers C; Bekaii-Saab T
Oncotarget; 2015 Sep; 6(26):22206-13. PubMed ID: 26082439
[TBL] [Abstract][Full Text] [Related]
8. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
9. MET expression and amplification in patients with localized gastric cancer.
Janjigian YY; Tang LH; Coit DG; Kelsen DP; Francone TD; Weiser MR; Jhanwar SC; Shah MA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1021-7. PubMed ID: 21393565
[TBL] [Abstract][Full Text] [Related]
10. RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Catenacci DV; Cervantes G; Yala S; Nelson EA; El-Hashani E; Kanteti R; El Dinali M; Hasina R; Brägelmann J; Seiwert T; Sanicola M; Henderson L; Grushko TA; Olopade O; Karrison T; Bang YJ; Kim WH; Tretiakova M; Vokes E; Frank DA; Kindler HL; Huet H; Salgia R
Cancer Biol Ther; 2011 Jul; 12(1):9-46. PubMed ID: 21543897
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
[TBL] [Abstract][Full Text] [Related]
12. MET amplification, protein expression, and mutations in pulmonary adenocarcinoma.
Park S; Koh J; Kim DW; Kim M; Keam B; Kim TM; Jeon YK; Chung DH; Heo DS
Lung Cancer; 2015 Dec; 90(3):381-7. PubMed ID: 26791796
[TBL] [Abstract][Full Text] [Related]
13. Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.
Schmid E; Klotz M; Steiner-Hahn K; Konen T; Frisk AL; Schatz C; Krahn T; von Ahsen O
Biotech Histochem; 2017; 92(6):425-435. PubMed ID: 28836864
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
15. Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients.
Yin X; Zhang T; Su X; Ji Y; Ye P; Fu H; Fan S; Shen Y; Gavine PR; Gu Y
PLoS One; 2015; 10(12):e0143468. PubMed ID: 26636767
[TBL] [Abstract][Full Text] [Related]
16. Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.
Peng Z; Li Z; Gao J; Lu M; Gong J; Tang ET; Oliner KS; Hei YJ; Zhou H; Shen L
Mol Cancer Ther; 2015 Nov; 14(11):2634-41. PubMed ID: 26330547
[TBL] [Abstract][Full Text] [Related]
17. MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.
Guo R; Berry LD; Aisner DL; Sheren J; Boyle T; Bunn PA; Johnson BE; Kwiatkowski DJ; Drilon A; Sholl LM; Kris MG
J Thorac Oncol; 2019 Sep; 14(9):1666-1671. PubMed ID: 31228623
[TBL] [Abstract][Full Text] [Related]
18. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
Ahn S; Hong M; Van Vrancken M; Lyou YJ; Kim ST; Park SH; Kang WK; Park YS; Jung SH; Woo M; Lee J; Kim KM
Mol Diagn Ther; 2016 Aug; 20(4):375-83. PubMed ID: 27179810
[TBL] [Abstract][Full Text] [Related]
19. MET amplification as a potential therapeutic target in gastric cancer.
Kawakami H; Okamoto I; Arao T; Okamoto W; Matsumoto K; Taniguchi H; Kuwata K; Yamaguchi H; Nishio K; Nakagawa K; Yamada Y
Oncotarget; 2013 Jan; 4(1):9-17. PubMed ID: 23327903
[TBL] [Abstract][Full Text] [Related]
20. MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.
Lee HE; Kim MA; Lee HS; Jung EJ; Yang HK; Lee BL; Bang YJ; Kim WH
Br J Cancer; 2012 Jul; 107(2):325-33. PubMed ID: 22644302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
